Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Clear Cell Papillary Renal Cell Carcinoma: Case Series with Review of the Literature.
J West Afr Coll Surg
July 2024
Department of Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Clear cell papillary renal cell carcinoma (CCPRCC) was included as a separate entity in the World Health Organisation classification of renal tumours in 2016. Immuno-histopathological and genetic characteristics are much known, but still, clinical features and long-term follow-up require more consolidated data. We report three cases of CCPRCC, detected in different clinical settings.
View Article and Find Full Text PDFSinonasal Adenocarcinomas: An Update.
Surg Pathol Clin
December 2024
Department of Translational Research, Section of Pathology, University of Pisa 56124, Italy. Electronic address:
Article Synopsis
- Adenocarcinomas are the second most common sinonasal malignancies, following squamous cell carcinoma.
- They include various subtypes such as intestinal-type adenocarcinoma (ITAC) and non-intestinal-type adenocarcinomas (non-ITACs).
- ITAC resembles gastrointestinal cancers with diverse growth patterns and mucin production, while non-ITACs lack clear histopathological features and are mainly diagnosed by exclusion.
Gelatinous Pleural Effusion: A Diagnostic Challenge for Pleural Mesothelioma in an 80-Year-Old Man.
Am J Case Rep
October 2023
Department of Respiratory Medicine, Northern Lincolnshire and Goole NHS Foundation Trust, Grimsby, United Kingdom.
BACKGROUND Gelatinous pleural effusion, due to raised hyaluronic acid, can be associated with pleural infection and malignancies, such as tuberculosis, metastatic pleural disease, and mesothelioma. This report is of an 80-year-old man presenting with a gelatinous pleural effusion and diagnosis of pleural mesothelioma. CASE REPORT An 80-year-old man with diabetes mellitus, ischemic heart disease, metastatic prostate cancer, 30-pack-year smoking history, and 5-year history of asbestos exposure (during his 30s), presented with a 4-week history of breathlessness and was found to have right-sided pleural effusion.
View Article and Find Full Text PDFUnique Growth Pattern Presentation of a Papillary Renal Cell Carcinoma.
Diagnostics (Basel)
August 2022
Department of Functional Sciences, Immuno-Physiology and Biotechnologies Center, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Sq. No. 2, 300041 Timisoara, Romania.
Papillary renal cell carcinoma (PRCC) is defined by the WHO 2022 classification as a malignant tumor derived from the renal tubular epithelium. However, the WHO 2016 classification subdivided PRCC into two types, with type 1 PRCC showing papillae covered by a single layer of neoplastic cells, and type II PRCC, which can show multiple types of histologies and is more aggressive. The WHO 2022 classification eliminated the subcategorization of PRCC.
View Article and Find Full Text PDFRecently Described Entity of Intracholecystic Papillary Neoplasm of Gallbladder with Coexisting Xanthogranulomatous Cholecystitis: an Unusual Association.
Indian J Surg Oncol
December 2021
Department of Pathology, Hamdard Institute of Medical Sciences and Research, Jamia Hamdard, New Delhi, 110062 India.
Intracholecystic papillary neoplasm (ICPN) of the gallbladder is a relatively new concept and is suspected to share clinicopathologic features with intraductal papillary mucinous neoplasm (IPMN) of the pancreas and intraductal papillary neoplasm of the bile duct (IPNB). The literature on the clinicopathologic characteristics of preinvasive intraepithelial neoplasms of the gall bladder is fairly limited, partly owing to variability in its definition and terminology. We report an extremely rare case of coexistent xanthogranulomatous inflammation and intracholecystic tubulo-papillary neoplasm with low-grade dysplasia in a 48-year-old male patient.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!